Systemic fungal infections pose a serious clinical problem. Treatment options are limited,
and antifungal drug resistance is increasing. In addition, a substantial proportion of patients …

Biofilms are widespread in nature and constitute an important strategy implemented by
microorganisms to survive in sometimes harsh environmental conditions. They can be …

Candida albicans is among the most prevalent fungal species of the human microbiota and
asymptomatically colonizes healthy individuals. However, it is also an opportunistic …

The high rates of morbidity and mortality caused by fungal infections are associated with the
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …

Highlights•Biofilm formation is a major contributor to pathogenesis during Candida
infection.•C. albicans biofilm formation is a multi-step, highly regulated process.•Cells in …

The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable
attention as a source of healthcare–associated infections. We report that this highly virulent …

Candida tropicalis has emerged as one of the most important Candida species. It has been
widely considered the second most virulent Candida species, only preceded by C. albicans …

Cells from all kingdoms of life produce extracellular vesicles (EVs). Their cargo is protected
from the environment by the surrounding lipid bilayer. EVs from many organisms have been …

Biosurfactants derived from different microbes are an alternative to chemical surfactants,
which have broad applications in food, oil, biodegradation, cosmetic, agriculture, pesticide …

Fungal biofilm infections have become increasingly recognised as a significant clinical
problem. One of the major reasons behind this is the impact that these have upon treatment …